Related Experiment Video
Updated: Aug 24, 2026

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
In vitro activity of anidulafungin against selected clinically important mold isolates
Zekaver Odabasi1, Victor L Paetznick, Jose R Rodriguez
1Laboratory of Mycology Research, Division of Infectious Diseases, University of Texas-Houston Medical School, Houston, Texas 77030, USA.
Abstract:
In this study, we evaluated the in vitro activity of anidulafungin against selected mold isolates. Anidulafungin showed promising activity against Bipolaris spicifera, Exophiala jeanselmei, Fonsecaea pedrosoi, Madurella mycetomatis, Penicillium marneffei, Phialophora verrucosa, Pseudallescheria boydii, Sporothrix schenckii, and Wangiella dermatitidis.
Insights
Anidulafungin demonstrated effective in vitro antifungal activity against several significant mold species. This research highlights its potential for treating mold infections caused by Bipolaris spicifera and Fonsecaea pedrosoi.
Area of Science:
- Mycology
- Antifungal Research
- Infectious Diseases
Background:
- Mold infections pose a significant clinical challenge, often requiring effective antifungal therapies.
- Echinocandin antifungals, like anidulafungin, are crucial in managing invasive fungal infections.
- Limited data exists on the in vitro susceptibility of certain emerging mold pathogens to anidulafungin.
Purpose of the Study:
- To assess the in vitro antifungal efficacy of anidulafungin.
- To determine the activity spectrum of anidulafungin against a panel of clinically relevant mold isolates.
Main Methods:
- In vitro susceptibility testing was performed on selected mold isolates.
- Anidulafungin's inhibitory concentrations were determined against various fungal species.
Main Results:
- Anidulafungin exhibited promising in vitro activity against Bipolaris spicifera.
- Effective activity was also observed against Exophiala jeanselmei, Fonsecaea pedrosoi, Madurella mycetomatis, Penicillium marneffei, Phialophora verrucosa, Pseudallescheria boydii, Sporothrix schenckii, and Wangiella dermatitidis.
Conclusions:
- Anidulafungin demonstrates broad-spectrum in vitro activity against a range of medically important molds.
- These findings support further investigation of anidulafungin for treating mold-related infections.
Related Concept Videos
Antifungal Agents
Fungal Group Zygomycota

